.Avidity Biosciences impressed financiers along with period 1/2 information in Duchenne muscular dys...
.Actinogen Medical's cortisol blocker has missed out on the key endpoint of a stage 2 research in de...
.Antibody-drug conjugates (ADCs) have been at the facility of many a billion-dollar biobuck licensin...
.Possession supervisor TPG, which has supported biotechs like Sionna Rehabs and Santa Clam Ana Biogr...
.Merck & Co.'s TIGIT program has suffered yet another trouble. Months after shuttering a period 3...
.After a year determined through pipe cuts, the variation of its own chief executive officer and als...
.Cullinan Therapy was wowed good enough with Harbour BioMed's bispecific immune system reactor that ...
.In this week's incident of "The Top Line," our team're diving into Brutal Biotech's annual Strong 1...
.The confetti is actually still flying from Eli Lilly's gathering commemorating the approval of Alzh...
.Invite to this week's Chutes & Ladders, our roundup of significant management hirings, shootings...